Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Treatment/Intervention:  complementary or alternative medicine procedure
Results 1-25 of 75 for your search:
Start Over
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: 97115, NCI-2011-02073, CDR0000674208, WF 97115, WFU-97115, MDA-04-01, NCT01141231
Acupuncture in Preventing Radiation-Induced Xerostomia
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2010-0584, NCI-2011-00306, NCT01266044
Acupressure in Controlling Nausea in Young Patients with Central Nervous System or Solid Tumors Receiving Nausea-Inducing Chemotherapy
Phase: Phase III
Type: Supportive care
Age: 4 to 18
Trial IDs: SCUSF 1202, NCI-2011-02668, ACCL1032, CDR0000699766, COG-ACCL1032, NCT01346267
Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Patients with Early-Stage Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: Postmenopausal
Trial IDs: S1200, NCI-2012-00251, CDR0000725249, SWOG-S1200, NCT01535066
The Effects of Ginseng on Cancer-Related Fatigue
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0854, NCI-2011-01127, NCT01375114
Acupuncture in Treating Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2012-1054, NCI-2014-01520, NCT01815346
Acupuncture in Treating Chemotherapy-Induced Neuropathy in Cancer Survivors
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2013-0930, NCI-2014-01466, NCT02168894
Acupuncture or Gabapentin in Treating Breast Cancer Survivors With Hot Flashes
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: UPCC 16108, NCI-2009-01315, NCT01005108
Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: UPCC 07109, NCI-2009-01358, NCT01013337
Genistein in Reducing the Toxicity and Improving the Efficacy of BCG Intravesical Therapy in Patients with Bladder Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: EU2010-11, NCI-2014-02088, IRB00050273, NCI-2014-02072, NCT01489813
Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents
Phase: Phase II
Type: Educational/Counseling/Training, Supportive care
Age: 11 to 24
Trial IDs: ANUR1131, NCI-2012-00682, CDR0000726664, COG-ANUR1131, NCT01556256
Ascorbic Acid, Gemcitabine Hydrochloride, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: 11D.365, NCI-2012-00340, 2008-52(1), NCT01555489
Yoga in Decreasing Inflammation, Fatigue, and Depressive Symptoms in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and over
Trial IDs: OSU-06137, NCI-2012-00564, 2007C0004, OSU-2007C0004, NCT00486525
Fish Oil in Preventing Colorectal Cancer in Participants Previously Diagnosed with Colon Polyps
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 79
Trial IDs: VICC GI 14138, NCI-2015-00480, 11165, GI 14138, NCI-2015-00070, NCT01661764
Curcumin in Reducing Fatigue in Patients with Chemotherapy-Treated Breast Cancer Undergoing Radiotherapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: WINSHIP2139-11, NCI-2014-02195, NCT01740323
Calcitriol before Surgery in Preventing Calcium Loss in Patients Undergoing Thyroidectomy
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TC-P2-CALCITRIOL, NCI-2014-00962, NCT01868750
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Green Tea Extract in Treating Patients with Low-Risk Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 45 to 85
Trial IDs: CASE 6812, NCI-2013-01372, NCT01928485
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients with Localized Prostate Cancer Undergoing Active Surveillance
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 and over
Trial IDs: CO11378, NCI-2014-00695, N01-CN-2012-00033, UWI2013-00-01, NCT02095145
Curcumin and Cholecalciferol in Treating Patients with Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 5913, NCI-2014-00266, NCT02100423
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GHNSCLC-2 001, NCI-2014-02209, NCT02047344
High-Dose Ascorbic Acid in Treating Patients with Stage IIIB-IV Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201412760, NCI-2015-00709, NCT02420314
Basiliximab in Treating Patients with Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Phase: Phase I
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: Pro00000581, NCI-2011-03848, CDR0000579683, SPORE Project 3, DUMC-PRO00000581, NCT00626483
Start Over